50,000 Patients, One Goal
As a member of US Oncology Research, Maryland Oncology Hematology is pleased to provide our patients access to cutting-edge and innovative clinical trials in a comfortable and convenient setting. US Oncology Research, supported by McKesson Specialty Health, recently announced that it has surpassed the 50,000 milestone for patients enrolled in its clinical trials program.
One of the largest and most reputable community-based research networks in the world, US Oncology Research specializes in Phase I–IV oncology clinical trials and has participated in over 1,200 investigator-initiated and sponsor-initiated trials since its inception. The program brings innovative therapies and clinical trials to practices and patients in communities across the nation to help advance the science of cancer care while offering the best possible treatments and improved patient outcomes.
Clinical Trials at Maryland Oncology Hematology
We are dedicated to advancing cancer care by leading and participating in clinical trials that test the safety and efficiency of new or modified treatments. These trials help uncover new treatment options and give many patients the opportunity to receive newly developed therapies or investigational drugs not yet available outside the study.